fantom, this company stumbled over the past 5 years. At one point, they were on a great sales trajectory, however, they floundered away great opportunities. They have mismanaged their trials. Thank goodness Germany stepped up to run and fund their own trial. This has not been a strength of this company. Maybe, just maybe, with the new CMO...they will get a trial completed. But this is years away IMO.
The company has a high market cap given all of its issues. The company is not profitable and won't be for some time. The stock price is currently at 12-13x sales. That is high for a company that hasn't been growing at a high rate. This virus is the best thing this company could have asked for. It has raised awareness for the cytokine storm and their blood purification technology. Once again, there is a huge opportunity for this company to thrive. Are they up for the challenge?
I'm not on board with Capponi becoming president. They needed to pull someone in from Fresenius or another major company. Capponi is a no-name with limited credibility. Now they have a Chairman (Krauss), CEO (Chan), and President/COO (Capponi). They are top-heavy without someone who can hit it out of the park.
I own a lot of shares of this company and expect a whole lot more. Let's see whether they can execute on this opportunity to bring it up to the type of company we expected to see years ago.
News 
Market Data 
Discover 
